Acute arterial occlusion following inadvertent infusion of ferric hydroxide sacarate (Noripurum®) into the radial artery: case report

Abstract

Iron overload, whether acute or chronic, has been implicated in the pathogenesis of ischemic cardiovascular diseases. However, its effects on peripheral vascular function and thrombotic responses to endothelial injury remain incompletely elucidated. We present a case of inadvertent intra-arterial infusion of ferric hydroxide saccharate (Noripurum®), resulting in severe acute arterial occlusion, most likely secondary to diffuse endothelial injury. Despite prompt surgical intervention and adjunctive pharmacological therapy, the clinical outcome was unfavorable. Given the lack of similar reports in major scientific databases and the involvement of complex, yet poorly characterized, interactions between iron overload and endothelial dysfunction, this case contributes valuable insights into the vascular implications of parenteral iron administration.

Keywords:
arterial occlusion; oxidative stress; vasculitis; case report

Resumo

A sobrecarga de ferro, seja aguda ou crônica, tem sido associada a eventos adversos na patogênese de doenças cardiovasculares isquêmicas. No entanto, os efeitos do excesso de ferro na função vascular periférica e na resposta trombótica à lesão endotelial ainda não são bem compreendidos. Reportamos um caso de infusão arterial inadvertida de sacarato de hidróxido férrico (Noripurum®), que ocasionou um quadro de oclusão arterial aguda severa por provável lesão endotelial difusa e que, mesmo após tratamento cirúrgico e terapia medicamentosa, não evoluiu satisfatoriamente. Como não encontramos relatos semelhantes na literatura nas principais bases de dados disponíveis e por envolver reações complexas ainda não compreendidas entre sobrecarga de ferro e lesão endotelial dos vasos, optamos por fazer este relato.

Palavras-chave:
oclusão arterial; estresse oxidativo; vasculite; relato de caso

INTRODUCTION

While iron is essential for many physiological processes, in excess it can trigger damage to tissues because of production of reactive oxygen species (ROS) generated by complex reactions.¹ Secondary iron overload can be caused by frequent blood transfusions or parenteral infusions of substances.² While controversies remain, several bodies of evidence suggest that excess iron can predispose to development of vascular diseases. Elevated levels of iron stores in the body were associated with an increased risk of myocardial infarction in a large cohort of men from Finland.³

In vitro studies have demonstrated that iron acutely induces platelet aggregation,⁴ whereas iron chelation can inhibit expression of tissue factor.⁵ However, the effects of chronic and acute iron overload on endothelium and the coagulation cascade are still poorly understood.

Iron can also exert direct effects on vascular structures, because local ROS production reduces bioavailable nitric oxide (NO) levels, compromising vascular wall relaxation, predisposing to platelet adhesion and aggregation as a consequence.⁶ There is therefore a relationship between endothelial dysfunction and thrombosis, both potentially mediated by oxidative stress.⁷

Recent studies have shown that after intravenous iron infusions are administered for supplementation, there is a greater than five times increase in levels of non-transferrin-bound iron. While the clinical significance of this increase has not been fully elucidated, in vitro evidence indicates that iron in this form can act as a catalyzer of generation of toxic ROS.⁸ The same studies emphasize the importance of the endothelium — in particular of endothelial NO — as a primary mechanism of defense against development of atherosclerotic lesions.⁹,¹⁰

In a murine model of acute iron overload in conjunction with hemolytic reaction, Asperti and Vinchi¹¹ demonstrated iron- and oxidative stress-mediated endothelial injury that was partially reversed using carbon-monoxide-releasing molecules.¹¹

In view of the changes to vascular endothelium induced by iron, and with the objective of improving understanding of this interaction and its possible complications, we present the following case report.

CASE REPORT

The patient was a 41-year-old female who sought care at an emergency room during the postoperative period after plastic surgery, complaining of weakness, with no other associated conditions. She was given two units of packed red blood cells. The following day, she returned to the urgent care center with similar symptoms and was prescribed intravenous infusion of ferric hydroxide saccharate (Noripurum®).

Due to difficulty obtaining peripheral venous access, the patient was transferred to the surgical center, where venous access was attempted by puncture of the right wrist, in an area close to the anatomical snuffbox. A short time after the infusion was started, she complained of intense pain, accompanied by paresthesia, dormancy, coldness, and cyanosis of the hand and fingers (Figures 1a and 1b). The brachial, radial, and ulnar pulses were absent on physical examination.

Figure 1
(a) and (b) Appearance of the hand after arterial occlusion.

The patient was promptly examined by a vascular surgeon, who conducted a Doppler ultrasonography examination of the arteries of the right upper limb, identifying occlusion of the brachial, radial, and ulnar arteries and observing thrombi with a recent appearance along the entire length of these arteries. She was taken to the surgical center, where she underwent arterial embolectomy via a brachial artery access in the cubital fossa, using Fogarty catheters numbers 3 and 4. The procedure removed large quantities of thrombi with acute characteristics (Figure 2). At the end of this intervention, the brachial, radial, and ulnar pulses were observed to be present and there was adequate perfusion of the right hand. The patient was kept on full anticoagulation (enoxaparin sodium 1 mg/kg every 12 h).

Figure 2
Fragments of thrombi after embolectomy.

Some hours after the procedure, the patient’s clinical status relapsed, and arterial embolectomy was performed again using the same devices as previously. The procedure was again successful and the patient was kept on full anticoagulation (enoxaparin sodium 1 mg/kg every 12 h). On the following day, the patient once more exhibited signs compatible with acute arterial occlusion of the right upper limb. This time she was taken to the catheterization laboratory, where she underwent arteriography, which demonstrated occlusion of the axillary artery and opacification of the distal vessels of the right upper limb (Figures 3a and 3b).

Figure 3
(a) and (b) Preoperative angiography.

In view of this clinical status, it was decided to perform embolectomy of the brachial, radial, and ulnar arteries, with access obtained via the cubital fossa and the distal third of the right forearm. Additionally, a 10 mg dose of a thrombolytic agent (alteplase) was administered directly into the arteries of the palmar arches, by intra-arterial infusion with a number 4 Nelaton probe, which was successful. Control arteriography demonstrated the vessels were patent and physical examination found the radial pulse was present and digital perfusion was good, with adequate oximetry readings (Figures 4a-d).

Figure 4
(a-d) Postoperative angiography.

However, a few hours later, the patient suffered another episode of acute arterial occlusion. From this point on, clinical treatment was continued with full parenteral anticoagulation (enoxaparin sodium 1 mg/kg every 12 h) and administration of prostaglandin E1 (Alprostadil alfadex® 80 mcg every 12 h).

Despite these measures, the patient’s right upper limb developed gangrene and required surgical amputation just above the cubital fossa (Figure 5). The amputation stump healed well and there were no further complications. The sequence of clinical events is described in Table 1.

Figure 5
Amputation stump.

Table 1
Timeline of the clinical case.

Date/Period	Event
Day 0	Infusion of two units of packed red blood cells after plastic surgery.
Day 1	Prescription of intravenous Noripurum® with inadvertent infusion into the radial artery.
Day 1 (after infusion)	Intense pain, paresthesia and cyanosis of right upper limb; diagnosis of acute arterial occlusion.
Day 1 (after first embolectomy)	First arterial embolectomy (Fogarty catheters sizes 3 and 4) with removal of acute thrombi.
Day 1 (after second embolectomy)	De novo arterial occlusion; second embolectomy, initially successful.
Day 2	Arteriography shows occlusion of the axillary artery; third embolectomy + thrombolysis.
Following days	Recurrent arterial occlusion; clinical management with full anticoagulation and prostaglandins.
Day 7	Progression to gangrene and amputation above the cubital fossa.

Specimens of proximal and distal arterial segments were sent for anatomic pathology analysis, which showed foci of endothelial destruction and focal areas of vascular wall necrosis, associated with transmural neutrophil infiltration, compatible with neutrophilic vasculitis (Figures 6a and 6b).

Figure 6
(a) and (b) Histopathological slides.

DISCUSSION

Inadvertent intra-arterial infusion of substances or medications is well-documented in the scientific literature, which describes manifestations along a varied clinical spectrum, ranging from local cutaneous lesions to serious complications, such as loss of limbs.¹²,¹³

The first study to demonstrate direct evidence that iron overload provokes ROS production in the vascular wall was conducted by Greenwood et al.¹⁴ These authors observed that accumulation of iron increased lipid peroxidation and local production of ROS, corroborating the hypothesis that excess iron amplifies oxidative stress in vivo. In animal models, particularly with rats, it has also been observed that vascular relaxation is impaired, attributed to reduced NO bioavailability, contributing further evidence of the link between oxidative stress and endothelial dysfunction.⁶

In another study, Rooyakkers et al.¹⁵ demonstrated that acute infusion of ferric saccharate at dosages commonly used for intravenous supplementation in patients on hemodialysis resulted in an up to four times increase in levels of non-transferrin-bound iron, in addition to provoking a transitory reduction in vascular wall relaxation. Non-transferrin-bound iron can act as a catalyst of ROS formation, contributing to endothelial toxicity. The study concluded that administration of ferric saccharate at therapeutic doses can cause reversible endothelial dysfunction in healthy individuals.

In the present case, pathology results for the arterial specimen revealed a picture compatible with neutrophilic vasculitis, probably triggered by the agent that had been infused. Known pathophysiologic mechanisms underlying this type of vasculitis include an aberrant inflammatory response, often associated with paraneoplastic or drug-induced conditions.

From a surgical point of view, this case illustrates the difficulty of managing severe and recurrent acute arterial occlusion. Despite immediate and successive embolectomy procedures, which restored perfusion, each procedure was followed by early relapse of thrombosis, resulting in multiple interventions over a short period of time. Addition of intra-arterial thrombolysis to surgical treatment was also insufficient to prevent progression of the ischemic condition, culminating in major amputation of the involved limb. This outcome underscores the importance of early surgical intervention, but also demonstrates its limitations in scenarios of extensive endothelial injury, in which even repeated interventions may not ensure limb viability.

Patient consent

The patient gave her consent to publication of this case report, including the images and clinical data presented.

Ethical considerations

This study was submitted for Research Ethics Committee analysis, via the Plataforma Brasil system, and was approved with Substantiated Opinion Number 7.472.451 and Ethics Appraisal Submission Certificate 85927624.3.0000.0035.

CONCLUSIONS

Analysis of the present case report supports the inference that intra-arterial iron administration can constitute a significant risk factor for occurrence of ischemic arterial events, secondary to endothelial injury and thrombosis. This risk appears to be linked to changes affecting both the coagulation cascade and the integrity and functionality of the endothelium.

DATA AVAILABILITY

The data supporting this study are available upon request from the corresponding author, DCMF, as they pertain to a patient, thus ensuring their privacy.

• How to cite:
  Fernandes DCM, Gusmao DR, Souza FMO, Santos JRS, Fidalgo BF. Acute arterial occlusion following inadvertent infusion of ferric hydroxide sacarate (Noripurum®) into the radial artery: case report. J Vasc Bras. 2026;25:e20250055. https://doi.org/10.1590/1677-5449.202500552
• Financial support:
  None.
• The study was carried out at Setor de Hemodinâmica, Instituto de Angiologia de Goiânia (IAG), Goiânia, GO, Brazil.
• Ethics committee approval:
  Research Ethics Committee Substantiated Opinion number: 7.472.451, Ethics Appraisal Submission Certificate: 85927624.3.0000.0035.

References

• ¹ Horwitz LD, Rosenthal EA. Iron-mediated cardiovascular injury. Vasc Med. 1999;4(2):93-9. https://doi.org/10.1177/1358836X9900400207 PMid:10406456.
  » https://doi.org/10.1177/1358836X9900400207
• ² Edwards CQ. Hemochromatosis and other iron storages disorders. In: Means RT, editor. Wintrobe’s clinical hematology. Philadelphia: Wolters Kluwer; 1993. p. 872-84.
• ³ Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 1992;86(3):803-11. https://doi.org/10.1161/01.CIR.86.3.803 PMid:1516192.
  » https://doi.org/10.1161/01.CIR.86.3.803
• ⁴ Praticò D, Pasin M, Barry OP, et al. Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C. Circulation. 1999;99(24):3118-24. https://doi.org/10.1161/01.CIR.99.24.3118 PMid:10377074.
  » https://doi.org/10.1161/01.CIR.99.24.3118
• ⁵ Penn MS, Cui MZ, Winokur AL, et al. Smooth muscle cell surface tissue factor pathway activation by oxidized low-density lipoprotein requires cellular lipid peroxidation. Blood. 2000;96(9):3056-63. https://doi.org/10.1182/blood.V96.9.3056 PMid:11049984.
  » https://doi.org/10.1182/blood.V96.9.3056
• ⁶ Russo G, Leopold JA, Loscalzo J. Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis. Vascul Pharmacol. 2002;38(5):259-69. https://doi.org/10.1016/S1537-1891(02)00250-1 PMid:12487030.
  » https://doi.org/10.1016/S1537-1891(02)00250-1
• ⁷ Day SM, Duquaine D, Mundada LV, et al. Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation. 2003;107(20):2601-6. https://doi.org/10.1161/01.CIR.0000066910.02844.D0 PMid:12732602.
  » https://doi.org/10.1161/01.CIR.0000066910.02844.D0
• ⁸ Gutteridge JMCHB. Iron and oxygen: a dangerous mixture. Boca Raton: CRC Press; 1990.
• ⁹ Gimbrone MA Jr. Vascular endothelium: an integrator of pathophysiologic stimuli in atherosclerosis. Am J Cardiol. 1995;75(6):67B-70B. https://doi.org/10.1016/0002-9149(95)80016-L PMid:7532351.
  » https://doi.org/10.1016/0002-9149(95)80016-L
• ¹⁰ Epstein FH, Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329(27):2002-12. https://doi.org/10.1056/NEJM199312303292706 PMid:7504210.
  » https://doi.org/10.1056/NEJM199312303292706
• ¹¹ Asperti M, Vinchi F. Improving CORM technology for the treatment of delayed hemolytic transfusion reaction. HemaSphere. 2024;8(8):e140. https://doi.org/10.1002/hem3.140 PMid:39104765.
  » https://doi.org/10.1002/hem3.140
• ¹² Yoshida WB, Rollo HA, Lastória S, et al. Isquemia de membro superior após injeção intramuscular de ampicilina benzatina e dipirona magnésica: relato de um caso. Cir Vasc Angiol. 1999;15:109-15.
• ¹³ Duque FLV, Chagas CAA. Acidente por injeção medicamentosa no músculo deltoide: lesões locais e à distância, revisão de 32 casos. J Vasc Bras. 2009;8(3):238-46. https://doi.org/10.1590/S1677-54492009000300009
  » https://doi.org/10.1590/S1677-54492009000300009
• ¹⁴ Greenwood SA, Beckley-Hoelscher N, Asgari E, et al. The effect of intravenous iron supplementation on exercise capacity in iron-deficient but not anaemic patients with chronic kidney disease: study design and baseline data for a multicentre prospective double-blind randomised controlled trial. BMC Nephrol. 2022;23(1):268. https://doi.org/10.1186/s12882-022-02896-3
  » https://doi.org/10.1186/s12882-022-02896-3
• ¹⁵ Rooyakkers TM, Stroes ES, Kooistra MP, et al. Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. Eur J Clin Invest. 2002;32(Suppl 1):9-16. https://doi.org/10.1046/j.1365-2362.2002.0320s1009.x PMid:11886426.
  » https://doi.org/10.1046/j.1365-2362.2002.0320s1009.x

Edited by

• Editor-in-Chief responsible
  Dr. Winston Bonetti Yoshida

Publication Dates

• Publication in this collection
  23 Mar 2026
• Date of issue
  2026

History

• Received
  01 May 2025
• Accepted
  10 Dec 2025